期刊文献+

新辅助化疗在结直肠癌治疗中的应用 被引量:2

Application of neoadjuvant chemotherapy in the treatment of colorectal cancer
原文传递
导出
摘要 结直肠癌是全球范围内第三种最常见的恶性肿瘤,是第二大癌症死亡原因,手术为主要治疗方法。由于早期结直肠癌症状不明显,大部分患者发现时已错失手术机会。对于肿瘤可切除患者,采取新辅助化疗,提高局部控制率和整体生存率;对于肿瘤不可切除患者,采取转化治疗,将其转变为可切除状态,随后行手术切除。新辅助化疗适用于肿瘤中期患者以及手术切除难度较大、不易完全切除的肿瘤,可使瘤体降期,使肿块缩小,以利于后续的手术、放疗等治疗。国内外研究发现,术前新辅助化疗有助于手术切除率的提高,并且使患者术后生存期得以延长。本文就新辅助化疗治疗结直肠癌的应用原则、疗效评估、临床获益及风险进行综述。 Colorectal cancer(CRC)is the third most common malignant tumor in the world and the second most common cause of cancer death.Surgery is the main treatment.Because the symptoms of colorectal cancer are not obvious in the early stage,most patients have missed the opportunity of surgery.For patients with resectable tumors,neoadjuvant chemotherapy is used to improve local control rate and overall survival rate.For patients with unresectable tumors,transformation therapy is used to transform them into resectable state,followed by surgical resection.Neoadjuvant chemotherapy is suitable for patients with tumor in middle stage or difficult to be resected as well as difficult to be removed completely.It can reduce the tumor stage and make the tumor shrink so as to facilitate subsequent surgery and radiotherapy.Domestic and foreign studies have found that preoperative neoadjuvant chemotherapy contributes to the improvement of surgical resection rate and prolongs postoperative survival of patients.This article reviews the application principles,efficacy evaluation,clinical benefits and risks of neoadjuvant chemotherapy in the treatment of colorectal cancer.
作者 杜莹 曹莉莉 Du Ying;Cao Lili(Department of Oncology,Shandong Provincial Qianfoshan Hospital,Shandong University,Jinan 250014,China;Department of Oncology,First Affiliated Hospital of Shandong First Medical University&Shandong Provincial Qianfoshan Hospital,Jinan 250014,China;Shandong Provincial Key Laboratory for Rheumatic Disease and Translational Medicine,Jinan 250014,China)
出处 《中华消化病与影像杂志(电子版)》 2023年第1期39-45,共7页 Chinese Journal of Digestion and Medical Imageology(Electronic Edition)
基金 山东省自然科学基金(ZR2020MH203) 山东省中医药科技发展计划(2019-0378) 山东第一医科大学第一附属医院培育基金(QYPY2019NSFC1015)
关键词 结直肠肿瘤 新辅助化疗 肝转移 多学科综合治疗 Colorectal cancer Neoadjuvant chemotherapy Hepatic metastases Multidisciplinary comprehensive treatment
作者简介 通信作者:曹莉莉,Email:ell@sdu.edu.cn.
  • 相关文献

参考文献12

二级参考文献308

  • 1陈功,万德森.2012V1版NCCN结肠癌指南更新解读[J].中国继续医学教育,2011,3(9):19-21. 被引量:10
  • 2袁瑛,曹文明,蔡善荣,张苏展.中国人遗传性非息肉病性结直肠癌家系的临床表型分析[J].中华肿瘤杂志,2006,28(1):36-38. 被引量:21
  • 3Stukel T.A.,Fisher E.S.,Wennberg D.E.,黄浙勇.对存在治疗选择偏倚的观察性研究的分析:采用倾向评分和工具变量法评价有创性心脏治疗对AMI患者生存率的影响[J].世界核心医学期刊文摘(心脏病学分册),2007,3(7):5-6. 被引量:4
  • 4Abdel-Misih SR,Schmidt CR,Bloomston PM.Update and review of the multidisciplinary management of stage Ⅳ colorectal cancer with liver metastases.World J Surg Oncol,2009,7:72.
  • 5Cantero-Muoz P,Urién MA,Ruano-Ravina A.Efficacy and safety of intraoperative radiotherapy in colorectal cancer:A systematic review.Cancer Lett,2011,306:121-133.
  • 6Gruenberger B,Tamandl D,Schueller J,et al.Bevacizumab,capecitabine,and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer.J Clin Oncol,2008,26:1830-1835.
  • 7Pozzo C,Barone C,Kemeny NE.Advances in neoadjuvant therapy for colorectal cancer with liver metastases.Cancer Treat Rev,2008,34:293-301.
  • 8Therasse P,Arbuck SG,Eisenhauer EA,et al.New guidelines to evaluate the response to treatment in solid tumors.European Organization for Research and Treatment of Cancer,National Cancer Institute of the United States,National Cancer Institute of Canada.J Natl Cancer Inst,2000,92:205-216.
  • 9Tsuchida Y,Therasse P.Response evaluation criteria in solid tumors (RECIST):new guidelines.Med Pediatr Oncol,2001,37:1-3.
  • 10Olde Bekkink M,McCowan C,Falk GA,et al.Diagnostic accuracy systematic review of rectal bleeding in combination with other symptoms,signs and tests in relation to colorectal cancer.Br J Cancer,2010,102:48-58.

共引文献264

同被引文献22

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部